◼ Archived
Business
Thyroid medicine recall receives FDA's highest risk level
A thyroid medication recall issued by Vitruvias Therapeutics has been upgraded by the FDA to the highest risk classification.
3 trends tracked about this subject — the full history, oldest to newest below.
A thyroid medication recall issued by Vitruvias Therapeutics has been upgraded by the FDA to the highest risk classification.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
18 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.